Announcement

Collapse
No announcement yet.

Re: Bionet controversial topic #6: on the obligation to shareuseful research data

Collapse
This topic is closed.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Re: Bionet controversial topic #6: on the obligation to shareuseful research data

    Sharing data and sharing models are different breeds of the same
    species. Both types of information should be shared for the good of the
    community.

    If I accept funding from a public agency and their aim is to promote the
    public good, then I am bound to share that aim and work towards it on their
    behalf. My personal belief is that sharing data is in the interest of
    overall public good. So we should embrace the concept of data sharing, and
    we should lobby for a way to make it as effective and easy for ourselves as
    possible.

    If we are privately funded, then the funding agency may request that the
    data be kept private. However, we are caught between competing
    duties; the duty to our funding agency, and the duty to the overall public
    good. There have been some very high profile cases recently regarding the
    rights to publication where scientists doing privately funded
    pharmaceutical researcher have found negative effects of relating to the
    use of drugs made by the company providing their funding. The duty to
    inform the public of the possible consequences of a particular drug is in
    direct conflict with the duty to the funding body. I see it as the
    responsibility of groups like the ISB, for example, to assist in developing
    policies regarding data sharing, and what conditions regarding publication
    of results are reasonable in funding contracts.

    The logistics of data sharing are not easy. Raw data by itself is
    useless. Unless the protocols for data collection are also shared, then
    interpreting the data meaningfully is highly unlikely. So, if we embrace
    the concept of data sharing, then we must also accept responsibility for
    sharing the research protocols.

    Documenting the data and protocols in a way that is rigorous and complete
    enough to be worth sharing would take some time and resources. So if a
    funding agency requires that the data be made public, then they should
    expect to see a section in the funding proposal relating to the time and
    resources required to do this. In addition, if it is mandated that the
    data reside in a public repository, then the group that mandates this must
    also accept responsibility for maintaining that repository.

    In short: We must embrace the concept of data sharing. It is essential
    that in funding contracts we secure the right to make the data public. We
    will have the most control of the data sharing paradigm if we work to
    develop the guidelines and have them adopted by regulatory and funding
    bodies rather than waiting for them to impose guidelines.

    Paul Ostic
    MSc Student
    Queen's University
    Kingston ON
    Canada

    ---------------------------------------------------------------
    To unsubscribe send SIGNOFF BIOMCH-L to LISTSERV@nic.surfnet.nl
    For information and archives: http://isb.ri.ccf.org/biomch-l
    ---------------------------------------------------------------
Working...
X